Looking for exposure in the pharma sector? Here are some worthy considerations
Pharma and healthcare sector have rewarded its investors handsomely in the couple of years. In this article we would be listing pharma funds that are worth considering.
Pharma and healthcare sector was in a downfall since 2015 which ended after five years in the year 2020 when the pandemic was hit. Though various sectors were hit badly during the pandemic, pharma and healthcare sector were heading northwards.
As you might have witnessed the steep rise during the pandemic, it has ran-up quite a bit and now seems to be cooling off. However, does it still make sense to invest in it at current juncture? For this we have to look at its valuations. As Nifty Healthcare Index has limited valuation history and 17 out of 20 constituents being pharma stocks, we will be looking at the valuations of Nifty Pharma Index.
Looking at the valuation metrics such as price to earnings (P/E) and price to book (P/B) ratios, the Nifty Pharma Index seems to be at an attractive valuation. Below we have listed the top pharma and healthcare funds that are worth considering.
Trailing Returns (%)
|
1-Year
|
3-Year
|
5-Year
|
DSP Healthcare Fund
|
11.18
|
29.41
|
-
|
Tata India Pharma & HealthCare Fund
|
11.33
|
24.37
|
13.68
|
UTI Healthcare Fund
|
10.61
|
23.28
|
12.24
|
SBI Healthcare Opportunities Fund
|
8.57
|
22.97
|
10.02
|
Nippon India Pharma Fund
|
10.27
|
22.83
|
16.13
|